Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)

ClinicalTrials.gov ID: NCT00048451

Public ClinicalTrials.gov record NCT00048451. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 8:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00048451
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
68 participants

Conditions and interventions

Interventions

  • paricalcitol Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2002
Primary completion
Not listed
Completion
Not listed
Last update posted
Aug 1, 2006

Started 2002

United States locations

U.S. sites
18
U.S. states
11
U.S. cities
18
Facility City State ZIP Site status
Tucson Therapeutic Research Institute, Inc. Tucson Arizona 85712
Not listed Pasadena California 91105
California Institute of Renal Research San Diego California 92120
Nephrology Educational Services and Research, Inc. Tarzana California 91356
Phoenix Internal Medicine Associates Waterbury Connecticut 06708
University of Florida Gainesville Florida 32610
Miami Kidney Group Miami Florida 33143
ICSL Clinical Studies Sarasota Florida 34232
Genesis Clinical Research Corporation Tampa Florida 33614
Evanston Northwestern Healthcare Evanston Illinois 60201
Medisphere Medical Research Center Evansville Indiana 47714
Ochsner Clinic Chronic Dialysis New Orleans Louisiana 70121
Biolab Research, LLC Rockville Maryland 20852
The Rogosin Institute New York New York 10021
Dialysis Clinic, Inc. Cincinnati Ohio 45206
Kidney Associates Houston Texas 77030
Texas Tech University Health Science Center Lubbock Texas 79430
University of Texas Health Science Center San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00048451, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 1, 2006 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00048451 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →